P561: VIALE-T: A RANDOMIZED, OPEN-LABEL, PHASE 3 STUDY OF VENETOCLAX IN COMBINATION WITH AZACITIDINE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

• C. Craddock,
• U. Platzbecker,
• M. Heuser,
• V. Pullarkat,
• S. Chaudhury,
• D. Wu,
• S. Addo,
• B. Chyla,
• Q. Jiang,
• P. Lee,
• J. E. Wolff

Affiliations

C. Craddock

1 University of Birmingham, Birmingham, United Kingdom

U. Platzbecker

2 University Hospital in Leipzig, Leipzig

M. Heuser

3 Hannover Medical School, Hannover, Germany

V. Pullarkat

4 City of Hope, Duarte, CA

S. Chaudhury

5 Ann & Robert H. Lurie Children’s Hospital of Chicago, Northwestern Feinberg School of Medicine, Chicago, United States of America

D. Wu

6 The First Affiliated Hospital of Soochow University, Soochow, China

S. Addo

7 AbbVie Inc, North Chicago, United States of America

B. Chyla

7 AbbVie Inc, North Chicago, United States of America

Q. Jiang

7 AbbVie Inc, North Chicago, United States of America

P. Lee

7 AbbVie Inc, North Chicago, United States of America

J. E. Wolff

7 AbbVie Inc, North Chicago, United States of America